Clinical Trials
Swiss-GO is here for you and your patient!
For evaluation and support for your research projects in the field of gynecological oncology and the coordination and implementation of your studies.
Expression VI (Carolin meets HANNA) Long-Term Survivors
In Switzerland, every year, approximately 800 women are diagnosed with ovarian, fallopian tube or peritoneal cancer. (Filler800 women are diagnosed with ovarian, fallopian tube or peritoneal)
MATAO newly diagnosed Ovarian Cancer
MATAO - A clinical phase III trial on the use of letrozole maintenance therapy for newly diagnosed advanced ovarian, fallopian tube or peritoneal cancers. (varian, fallopian tube or peritoneal cancers)
The IRMA Study
The IRMA Study is a multicenter observational cohort study of women undergoing immediate breast reconstruction following either prophylactic mastectomy or mastectomy due to breast cancer.
BOUQUET Trial: Rare Ovarian cancers
This study will evaluate the efficacy and safety of multiple biomarker-selected treatments in patients with persistent or recurrent rare epithelial ovarian, fallopian tube, or primary peritoneal tumors
Expression IX-Long-term survivors with gynecologic cancers
The survey Expression IX aims to survey patients worldwide with gynecologic tumor disease (uterine cancer, cervical cancer, endometrial cancer, and other rare tumors such as gynecologic sarcomas in the uterus or germline tumors such as granulosa cell tumors and Sertoli-Leydig cell tumors) using an anonymized questionnaire.
Expression XI-IMPROVE
The Expression XI-Improve study, is an international survey aimed at patients with uterine cancer (Endometrian cancer).
